Trials / Completed
CompletedNCT06897891
A Comparative Study on Relieving Postpartum Lumbago with Fire-dragon Cupping Therapy and Acupuncture
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Qiaohui Ye · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Abstract: Objective To compare the effects of fire dragon pot therapy and acupuncture on low back pain, lumbar function, self-efficacy and postpartum depression in patients with postpartum low back pain. Methods From April 2024 to September 2024, 84 postpartum patients with low back pain who met the standard of sodium discharge in Hangzhou area were recruited and divided into acupuncture group (routine acupuncture + core stability training (42 cases) and Huolongcan group (42 cases) according to random number table method. Fire dragon pot + core stability training (42 cases), the two groups each intervention 30 min, once every other day, intervention 3 times. Before and after the intervention, the visual Analogue Scale (VAS) was used to evaluate the degree of low back pain, the Oswestry Disability Index (ODI) was used to evaluate the lumbar function, the pain Self-efficacy questionnaire (PSEQ) was used to evaluate the patients' confidence in effectively coping with pain, and the Edinburgh Postpartum Depression Scale (EPDS) was used to evaluate the postpartum depression. The changes of each index before and after intervention were observed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Acupuncture combined with core stability training | All patients were given routine health education guidance and core stability training. Acupuncture group combined with core stability training |
| COMBINATION_PRODUCT | Dragon Tank joint core stability training | All patients were given routine health education guidance and core stability training. Huolong Tank group adopts Huolongcan combined core stability training |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-09-01
- Completion
- 2024-10-01
- First posted
- 2025-03-27
- Last updated
- 2025-03-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06897891. Inclusion in this directory is not an endorsement.